--- title: "Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R | Sutter Health" description: "Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)" url: "https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R # Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06909565). #### Locations - San Francisco #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION) ![Hernan A Bazan, M.D., DFSVS, FACS](https://dyn.mktgcdn.com/p/j7hdvr_qWGkLYeXPh7G-FcN0k8jZyKfEELrBFv3aLpk/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Hernan A Bazan, M.D., DFSVS, FACS Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/hernan-a-bazan-md-dfsvs-facs-2080050014) ## Sub-Investigators [Meghna Motiani, M.D., FACC](https://www.sutterhealth.org/research/investigators/meghna-motiani-md-facc-2093696744) , [Christian Spies, M.D.](https://www.sutterhealth.org/research/investigators/christian-spies-md-1078064875) , [Christopher Woods, M.D., Ph.D., FHRS](https://www.sutterhealth.org/research/investigators/christopher-woods-md-phd-fhrs-1049681085) ## Email us to enroll - [Email San Francisco](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Prevention%20of%20Cardiovascular%20and%20Limb%20Events%20in%20Patients%20Receiving%20Percutaneous%20Coronary%20or%20Peripheral%20Arterial%20Revascularization%20V-Intervention%20CKJX839D1US04R%20in%20San%20Francisco&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Cardiovascular Disease LAAOS-4](https://www.sutterhealth.org/research/clinical-trials/cardiovascular-disease-laaos-4-2005599287) The Fourth Left Atrial Appendage Occlusion Study (LAAOS-4) **Status:** Open to Enrollment - Clinical trial ### [Cardiovascular Global Paradise System US Post Approval Study (US GPS)](https://www.sutterhealth.org/research/clinical-trials/cardiovascular-recor-us-gps-1084355543) The Global Paradise® System US Post Approval Study (US GPS) **Status:** Open to Enrollment - Clinical trial ### [Severe Tricuspid Valve Regurgitation VDyne Transcatheter Tricuspid Valve Replacement CIP-CL-001 TRIVITA](https://www.sutterhealth.org/research/clinical-trials/severe-tricuspid-valve-regurgitation-vdyne-transcatheter-tricuspid-valve-replacement-cip-cl-001-trivita-2092096598) VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation **Status:** Open to Enrollment - Clinical trial ### [Ventricular Tachycardia FACiLE Activation Mapping](https://www.sutterhealth.org/research/clinical-trials/ventricular-tachycardia-facile-activation-mapping-2028367503) Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial **Status:** Open to Enrollment - Clinical trial ### [Aortic Stenosis with TAVI ET03 SHIELD](https://www.sutterhealth.org/research/clinical-trials/aortic-stenosis-with-tavi-et03-shield-2084630343) A Prospective, Randomized, Multicenter, Single-blind Trial to Assess the Safety and Effectiveness of the Encompass F2 Cerebral Protection System Vs. Standard of Care (Unprotected or Sentinel® Cerebral Protection System) During Transfemoral Transcatheter Aortic Valve Replacement **Status:** Coming Soon [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744#medicalwebpage","name":"Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R","description":"Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)","url":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744","inLanguage":"en-US","dateModified":"2026-10-06","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744#breadcrumblist"},"mentions":[{"@type":"Person","name":"Hernan A Bazan, M.D., DFSVS, FACS","url":"https://www.sutterhealth.org/research/investigators/hernan-a-bazan-md-dfsvs-facs-2080050014","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744#medicaltrial","name":"Prevention of Cardiovascular and Limb Events in Patients Receiving Percutaneous Coronary or Peripheral Arterial Revascularization V-Intervention CKJX839D1US04R","alternateName":"Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)","url":"https://www.sutterhealth.org/research/clinical-trials/prevention-of-cardiovascular-and-limb-events-in-patients-receiving-percutaneous-coronary-or-peripheral-arterial-revascularization-v-intervention-ckjx839d1us04r-2090287744","description":"Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION)","identifier":"NCT06909565","code":{"@type":"MedicalCode","codeValue":"NCT06909565","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT06909565","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Cardiovascular Diseases"},{"@type":"MedicalCondition","name":"General Cardiology"}],"studyLocation":[{"@type":"AdministrativeArea","name":"San Francisco"}]} ```